Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Ltd., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc. The biotech market is experiencing significant growth with trends such as genetic engineering and precision medicine leading ...

Regeneron Pharmaceuticals Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Thermo Fisher Scientific Inc., and Vertex Pharmaceuticals Inc. The biotech market is experiencing significant growth with ...

Government measures are expected to challenge pharmaceutical firms. Australia’s pharmaceutical market is projected to expand ...

This week’s episode of The Top Line dives into the discussion, featuring Fierce Biotech’s Gabrielle Masson ... biotechs that debuted on the public market in 2024, the keys to success for ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, ...

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from 2025-2029, according to Technavio.